Restylane is recognized as a leading treatment for correcting frown lines and holds the distinction of being the first and only FDA-approved dermal filler for lip enhancement. The work supported a full brand re-launch spanning a redesigned website and integrated campaign, bringing the updated benefits and treatment indications to life for both patients and practitioners.